LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year […]